The Role of the EU in Promoting Better Cancer Care and Outcomes

This event is the third and final instalment in the Ireland and the EU Health Union discussion series, which is supported by Janssen Sciences Ireland. This event focuses on the role of the EU in promoting better cancer care and outcomes across the Union, through various initiatives contained within the EU’s Beating Cancer Plan. As part of the new Health Union, the EU has identified cancer as a health priority. The EU is pursuing a number of major initiatives to improve care and reduce inequalities across the Union in areas such as medicines access, pharmaceutical legislation, genetic testing and diagnosis, and data sharing and research. In this session, experts, clinicians and patient representatives discuss the EU’s efforts to achieve these objectives and assess the EU’s Beating Cancer Plan. This panel also considers how Ireland compares to our European peers both in terms of levels of care and outcomes, and what lessons we can learn to improve care for Irish cancer patients.

The panel for this event consists of:

Senator Annie Hoey

Averil Power, CEO of the Irish Cancer Society

Barry Andrews, Member of the European Parliament

Professor Ray McDermott, Consultant Medical Oncologist

Dr Thorsten Giesecke, General Manager, Commercial Business, Janssen Sciences Ireland